Author: Harbour Biomed

Posted Date:

April 16, 2026

Harbour BioMed Appoints Dr. Adam Zong as President

Harbour Biomed

April 16, 2026
Harbour BioMed Reports Full Year 2025 Financial Results: Sustained Global Collaboration Underpins Long-Term Growth

Harbour Biomed

March 30, 2026
Harbour BioMed Reports the Online Publication of Phase I Results for HBM9378 (SKB378/WIN378), a TSLP-Targeting Antibody

Harbour Biomed

March 22, 2026
Harbour BioMed Appoints Dr. Jenny Xie as Chief Scientific Officer, Immunology and Head of Global External Innovation

Harbour Biomed

March 19, 2026
Harbour BioMed and Kelun-Biotech Announce NMPA Approval of IND Application for HBM7575/SKB575 for the Treatment of Atopic Dermatitis

Harbour Biomed

March 9, 2026
Harbour BioMed Announces Positive Profit Alert for 2025 Annual Results

Harbour Biomed

February 3, 2026
Nona Biosciences Co-founds Innovative Alliance for Translational Medicine in Immunological Diseases, Advancing a New IIT-Driven Ecosystem

Harbour Biomed

January 28, 2026